The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases
Date
2019xmlui.mirage2.itemSummaryView.MetaData
Show full item recordxmlui.mirage2.itemSummaryView.Collections
DSpace@LokmanHekim by Lokman Hekim University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..
